Endothelial dysfunction in COVID-19 is linked to hypercoagulability as indicated by increased fibrinogen and von Willebrand factor levels as well as elevated numbers of activated platelets and their complexes with leukocytes together with abnormal coagulation parameters (Spiezia et al., 2020; Tang et al., 2020b). The gene discussed is VWF; the disease is COVID-19.